Acetylation and Histone Deacetylase Inhibitors in Cancer

Ítems similars

• Acetylation and Histone Deacetylase Inhibitors in Cancer
  per: Madeleine S. Q. Kortenhorst, et al.
  Publicat: (2006-01-01)
• A Multiple Loop, Double Cube Microarray Design Applied to Prostate Cancer Cell Lines with Variable Sensitivity to Histone Deacetylase Inhibitors
  per: Kortenhorst, Madeleine S. Q., et al.
  Publicat: (2008)
• Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors
  per: Wissing, Michel D., et al.
  Publicat: (2013)
• Myelodysplastic Syndrome and Histone Deacetylase Inhibitors: “To Be or Not to Be Acetylated”?
  per: Stintzing, Sebastian, et al.
  Publicat: (2011)
• Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors
  per: Kortenhorst, Madeleine SQ, et al.
  Publicat: (2013)